The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances

doi:10.1016/j.vaccine.2026.128348

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances

Mathematics and Statistics

The George Washington University
Harvard Medical School
Baylor College of Medicine
Emory University School of Medicine
Duke University School of Medicine
New York University Grossman School of Medicine
University of California San Francisco
Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
Icahn School of Medicine at Mount Sinai

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	128348
Pages (from-to)	128348
Journal	Vaccine
Volume	76
DOIs	https://doi.org/10.1016/j.vaccine.2026.128348
State	Published - Mar 19 2026

Keywords

Adult
Amino Acid Sequence
Antibodies, Neutralizing/blood
Antibodies, Viral/blood
COVID-19 Vaccines/immunology
COVID-19/immunology
Female
Humans
Immunization, Secondary
Male
Middle Aged
SARS-CoV-2/immunology
Spike Glycoprotein, Coronavirus/immunology
United States/epidemiology

Access to Document

10.1016/j.vaccine.2026.128348

Cite this

@article{c8a2b0e2eb3f48748122716db9044375,

title = "The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances",

keywords = "Adult, Amino Acid Sequence, Antibodies, Neutralizing/blood, Antibodies, Viral/blood, COVID-19 Vaccines/immunology, COVID-19/immunology, Female, Humans, Immunization, Secondary, Male, Middle Aged, SARS-CoV-2/immunology, Spike Glycoprotein, Coronavirus/immunology, United States/epidemiology",

author = "Fei Heng and Magaret, \{Craig A.\} and Rouphael, \{Nadine G.\} and Branche, \{Angela R.\} and Youyi Fong and Carpp, \{Lindsay N.\} and Chenchen Yu and Shiyu Chen and Bo Zhang and Diemert, \{David J.\}",

year = "2026",

month = mar,

day = "19",

doi = "10.1016/j.vaccine.2026.128348",

language = "English",

volume = "76",

pages = "128348",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier",

}

TY - JOUR

T1 - The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances

AU - Heng, Fei

AU - Magaret, Craig A.

AU - Rouphael, Nadine G.

AU - Branche, Angela R.

AU - Fong, Youyi

AU - Carpp, Lindsay N.

AU - Yu, Chenchen

AU - Chen, Shiyu

AU - Zhang, Bo

AU - Diemert, David J.

PY - 2026/3/19

Y1 - 2026/3/19

KW - Adult

KW - Amino Acid Sequence

KW - Antibodies, Neutralizing/blood

KW - Antibodies, Viral/blood

KW - COVID-19 Vaccines/immunology

KW - COVID-19/immunology

KW - Female

KW - Humans

KW - Immunization, Secondary

KW - Male

KW - Middle Aged

KW - SARS-CoV-2/immunology

KW - Spike Glycoprotein, Coronavirus/immunology

KW - United States/epidemiology

UR - https://www.scopus.com/pages/publications/105031190017

UR - https://www.scopus.com/pages/publications/105031190017#tab=citedBy

UR - https://www.mendeley.com/catalogue/592dd06b-04ba-3a93-9841-f544006e87ff/

U2 - 10.1016/j.vaccine.2026.128348

DO - 10.1016/j.vaccine.2026.128348

M3 - Article

C2 - 41698311

AN - SCOPUS:105031190017

SN - 0264-410X

VL - 76

SP - 128348

JO - Vaccine

JF - Vaccine

M1 - 128348

ER -

The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances

Keywords

Access to Document

Other files and links

Cite this